Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China

被引:56
作者
Ma, Chun-fang [1 ]
Li, Fang-qiu [1 ,2 ]
Shi, Li-ning [1 ]
Hu, Yu-an [1 ]
Wang, Ying [1 ]
Huang, Mei [1 ]
Kong, Qian-qian [1 ]
机构
[1] Nanjing Univ, Jinling Hosp, Sch Med, Inst Med Lab Sci,Lab Mol Biol, Nanjing 210002, Jiangsu, Peoples R China
[2] Jinling Hosp, Inst Med Lab Sci, Lab Mol Biol, Nanjing 210002, Jiangsu, Peoples R China
来源
BMC INFECTIOUS DISEASES | 2013年 / 13卷
关键词
Nosocomial candidemia; Antifungal susceptibility; Mortality; Risk factors; BLOOD-STREAM INFECTIONS; POPULATION-BASED SURVEILLANCE; RISK-FACTORS; INTENSIVE-CARE; UNITED-STATES; EPIDEMIOLOGY; FUNGEMIA; VORICONAZOLE; MULTICENTER; NATIONWIDE;
D O I
10.1186/1471-2334-13-337
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Bloodstream infections due to Candida species cause significant morbidity and mortality, and the epidemiology of Candida infection is changing. Surveillance for candidemia is necessary to detect trends in species distribution and antifungal resistance. Methods: The medical and electronic records of all patients who had candidemia at the authors' hospital from 2009 to 2011 were reviewed for demographic data and clinical information, including the infecting Candida species, resistance to antifungals and survival, and the presence of risk factors associated with candidemia. Results: A total of 133 distinct episodes of candidemia were identified over the study period. The annual incidence of candidemia ranged between 0.71 and 0.85 cases/1000 hospital discharges. The most frequent Candida species were C. tropicalis (28.6%), followed by C. albicans (23.3%) and C. parapsilosis (19.5%). The rates of susceptibility to antifungal agents were as followed: voriconazole (97.8%), itraconazole (69.5%), fluconazole (46.1%), ketoconazole (38.9%). Out of 131 evaluable patients, 34 (26.0%) died within 30 days from the onset of candidemia. C. tropicalis candidemia was associated with the highest mortality rate (44.7%). Regarding the crude mortality in the different units, patients in Hemato-Oncology ward had the highest mortality rate (66.7%), followed by patients in cardiovascular wards and ICU (57.1% and 25.6%, respectively). Predictors of 30-day mortality were identified by uni- and multivariate analyses. Complicated abdominal surgery, presence of central venous catheter (CVC), neutropenia, candidemia due to C. tropicalis and poor treatment with fluconazole were significantly associated with the 30-day mortality. Presence of CVC (odds ratio[OR] = 4.177; 95% confidence interval [CI] = 1.698 to 10.278; P = 0.002) was the only independent predictor for mortality in the multivariate analysis. Conclusion: This report provides baseline data for future epidemiological and susceptibility studies and for the mortality rates associated with candidemia in our hospital. The knowledge of the local epidemiological trends in Candida species isolated in blood cultures is important to guide therapeutic choices.
引用
收藏
页数:9
相关论文
共 46 条
[1]   Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004 [J].
Al-Tawfiq, Jaffar A. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (03) :239-244
[2]   Epidemiology and predictors of mortality in cases of Candida bloodstream infection:: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003 [J].
Almirante, B ;
Rodríguez, D ;
Park, BJ ;
Cuenca-Estrella, M ;
Planes, AM ;
Almela, M ;
Mensa, J ;
Sanchez, F ;
Ayats, J ;
Gimenez, M ;
Saballs, P ;
Fridkin, SK ;
Morgan, J ;
Rodriguez-Tudela, JL ;
Warnock, DW ;
Pahissa, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (04) :1829-1835
[3]   National Surveillance of Fungemia in Denmark (2004 to 2009) [J].
Arendrup, Maiken Cavling ;
Bruun, Brita ;
Christensen, Jens Jorgen ;
Fuursted, Kurt ;
Johansen, Helle Krogh ;
Kjaeldgaard, Poul ;
Knudsen, Jenny Dahl ;
Kristensen, Lise ;
Moller, Jens ;
Nielsen, Lene ;
Rosenvinge, Flemming Schonning ;
Roder, Bent ;
Schonheyder, Henrik Carl ;
Thomsen, Marianne K. ;
Truberg, Kjeld .
JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (01) :325-334
[4]   Nationwide Study of Candidemia, Antifungal Use, and Antifungal Drug Resistance in Iceland, 2000 to 2011 [J].
Asmundsdottir, Lena Ros ;
Erlendsdottir, Helga ;
Gottfredsson, Magnus .
JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (03) :841-848
[5]   Epidemiological trends in nosocomial candidemia in intensive care [J].
Bassetti, M ;
Righi, E ;
Costa, A ;
Fasce, R ;
Molinari, MP ;
Rosso, R ;
Pallavicini, FB ;
Viscoli, C .
BMC INFECTIOUS DISEASES, 2006, 6 (1)
[6]   Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals [J].
Bassetti, Matteo ;
Trecarichi, Enrico Maria ;
Righi, Elda ;
Sanguinetti, Maurizio ;
Bisio, Francesca ;
Posteraro, Brunella ;
Soro, Ornella ;
Cauda, Roberto ;
Viscoli, Claudio ;
Tumbarello, Mario .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 58 (03) :325-331
[7]   Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study [J].
Blumberg, HM ;
Jarvis, WR ;
Soucie, JM ;
Edwards, JE ;
Patterson, JE ;
Pfaller, MA ;
Rangel-Frausto, MS ;
Rinaldi, MG ;
Saiman, L ;
Wiblin, RT ;
Wenzel, RP .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (02) :177-186
[8]   Candida tropicalis in human disease [J].
Chai, Louis Yi Ann ;
Denning, David W. ;
Warn, Peter .
CRITICAL REVIEWS IN MICROBIOLOGY, 2010, 36 (04) :282-298
[9]   Candidemia in the 21st century [J].
Chang, Amy ;
Neofytos, Dionissios ;
Horn, David .
FUTURE MICROBIOLOGY, 2008, 3 (04) :463-472
[10]  
Colosi I., 2009, Revista Scientia Parasitologica, V10, P112